# Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis

> **NCT07515066** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Huan Ye** · enrollment: 9 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis (IPF)

## Interventions

- **BIOLOGICAL:** 3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles
- **BIOLOGICAL:** 3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles
- **BIOLOGICAL:** 3D-cultured human placental mesenchymal stem cell-derived extracellular vesicles

## Key facts

- **NCT ID:** NCT07515066
- **Lead sponsor:** Huan Ye
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515066, "Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07515066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*